In High-intensity focused ultrasound (HIFU) highly aimed ultrasonic waves are employed to the local diseased tissue through ablation. This leads to the augment in temperature with the growing intensity of tissue vibrations. Once the temperature augments beyond 60 degrees Celsius, coagulative necrosis and protein denaturation happen which in turn leads to irreparable cell death. The advantages of utilizing the HIFU products in traditional ultrasound systems comprise less bleeding and low procedural duration. Moreover, surgical processes utilizing these devices are minimally invasive, cost-effective, as well as less painful. There are presently more than 125 clinical indications in which HIFU is engaged which are in several stages of development, and the number is augmenting rapidly. Globally, 31 indications have regulatory endorsement; in the US, while six have been permitted by the FDA.
In addition, Focused ultrasound is an initial phase, non-invasive therapeutic technology which advanced the lives of millions of patients suffering from serious medical situations. It delivers a disruptive, life-changing complement to surgery, drug delivery, radiation therapy, and cancer immunotherapy. High-intensity Focused Ultrasound (HIFU) augments the quality and longevity of life and deducts the treatment cost. Nowadays, it is utilized in the treatment of a broad range of indications, comprising: Benign and malignant tumors of the brain, breast, prostate, liver, and pancreas, Parkinson’s and Alzheimer’s diseases and epilepsy, Depression and obsessive-compulsive disorder, Arthritis and hypertension and Uterine fibroids.
According to the report analysis, ‘High-Intensity Focused Ultrasound (HIFU) Market: Current Analysis and Forecast (2021-2027)’ states that the requirement for High-intensity focused ultrasound (HIFU) market is augmenting on account of the high pervasiveness of cancer as well as cardiovascular disease cases, promulgating aging population, augmenting the number of new product launches, growing number of clinical trials, and high aim of market chief players on the development of technologically innovative systems. Moreover, the great recommendations by healthcare organizations (European Association of Urology, and the National Institute for Health and Clinical Excellence) on Focal therapy utilizing the HIFU system for localized prostate cancer are motivating the market growth.
Based on Methods, the market is classified into Non-invasive Methods and Minimal Invasive Methods. The non-invasive segment registered the market in 2020 and is projected to develop at lucrative during the reviewed period. Non-Invasive ultrasound stimulation is an improving technology that can noninvasively inhibit neural activity in the targeted brain by providing pulsed ultrasonic waves. The augmenting occurrence of the neurological, orthopedic, tooth, and gastrointestinal health issues among various chronic disorders is projected to generate an upsurge in demand for non-invasive approaches.
Not only has this, the North America will register the High-intensity focused ultrasound (HIFU) market on account of the owing to the significant growth in prevalence of cancers in this region, which is one of the foremost driving aspects for the growth of high intensity focused ultrasound (HIFU) therapy market. Therefore, it is predicted that during the review years the market of highly intensity focused ultrasound (HIFU) market more effectively over the coming period.
For More Information, refer to below link:-
Global High-Intensity Focused Ultrasound (HIFU) Market
Follow Us:-
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
